As of November 26, 2024, Bayer Aktiengesellschaft had a $19.5 billion market capitalization, putting it in the 88th percentile of companies in the Pharmaceuticals industry. Bayer Aktiengesellschaft ...
Bayer is known for selling seeds. Now it sells seeds and artificial intelligence. Microsoft today announced it is working with the German pharmaceutical-and-agricultural group and other ...
Bayer AG (BAYRY) is on track to meet its full-year targets for sales growth, core earnings per share, and free cash flow. The Pharmaceuticals division is performing well, with Nubeqa reaching ...
The climate crisis is a cost-of-living crisis. Because climate disasters are driving up costs for households and businesses. Worsening climate impacts will put inflation on steroids unless every ...
German pharmaceutical giant Bayer released its third quarter 2024 earnings on Tuesday, reporting net sales of €10.0bn, down from €10.3bn in the same period last year. The company’s share ...
Agriculture business to weigh further on 2025 earnings Bayer shares down 11.6% to two-decade low Investor urges more efforts, demands mid-term targets FRANKFURT, Nov 12 (Reuters) - Bayer (BAYGn.DE ...
It's quite something to suggest Bayer (OTCPK:BAYZF)(OTCPK:BAYRY) to not undervalued or attractive to invest in at this price and point in its "cratering" history. As I am writing this article ...
Bayer BAYN-5.19%decrease; red down pointing triangle cut its full-year earnings target after a tough agricultural market hit its crop-science division, and said it heads into next year with a ...
Investing.com -- Shares of Bayer (ETR:BAYGN) fell over 11% on Tuesday following disappointing Q3 results and a reduction in the company’s EBITDA guidance for the full year. Bayer reported a ...
Bayer said that the earnings measure, when adjusted for currency impacts, would likely be between 10.4 billion euros ($11.1 billion) and 10.7 billion euros, down from a previous 10.7-11.3 billion ...
Bayer reported a decline of 37% in earnings per share on Tuesday, which sent its stock down 12%. CEO Bill Anderson urged investors to be patient as the company executes on a performance-boosting ...